In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition

G Mahalingam, S Marepally - Molecular Therapy, 2024 - cell.com
In a world grappling with the evolving variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), another emerging respiratory virus, respiratory syncytial virus …
相关文章

[引用][C] In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition

G Mahalingam, S Marepally - Molecular therapy: the …, 2024 - pubmed.ncbi.nlm.nih.gov
In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to
overcome antigenic competition In a quest for bivalent mRNA vaccine for respiratory viruses …

[引用][C] In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition.

G Mahalingam, S Marepally - Molecular Therapy: the Journal of the …, 2024 - europepmc.org
In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome
antigenic competition. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …